Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.69 |
| ▸ | MAPT | P10636 | 2/20 | 0.69 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.69 |
| ▸ | HPGD | P15428 | 1/20 | 0.69 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.69 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 0.69 |
| ▸ | ABHD5 | Q8WTS1 | 1/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CASP3 | P42574 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.42 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.42 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5933920 | 1.00 | ALDH1A1 (0.69) | ALDH1A1MAPTPLIN1HPGDALOX15 | |
| SCHEMBL17602874 | 0.84 | ALDH1A1 (0.57) | ALDH1A1MAPTPLIN1HPGDALOX15 | |
| SCHEMBL11115778 | 0.83 | ALDH1A1 (0.64) | ALDH1A1MAPTPLIN1HPGDALOX15 | |
| Phosmet SCHEMBL3620 | 0.82 | ALDH1A1 (1.00) | ALDH1A1MAPTPLIN1HPGDALOX15 | |
| Phosmet SCHEMBL1663406 | 0.82 | ALDH1A1 (1.00) | ALDH1A1MAPTPLIN1HPGDALOX15 | |
| Phosmet SCHEMBL29350557 | 0.82 | ALDH1A1 (1.00) | ALDH1A1MAPTPLIN1HPGDALOX15 | |
| SCHEMBL13596981 | 0.76 | ALDH1A1 (0.81) | ALDH1A1MAPTPLIN1HPGDALOX15 | |
| SCHEMBL571793 | 0.75 | PLIN1 (0.55) | ALDH1A1MAPTPLIN1HPGDALOX15 | |
| Phosmet SCHEMBL7246728 | 0.75 | ALDH1A1 (0.84) | ALDH1A1MAPTPLIN1HPGDALOX15 | |
| SCHEMBL4124410 | 0.75 | ALDH1A1 (0.54) | ALDH1A1MAPTPLIN1HPGDALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250032519-A1 | HIGH POTENCY EMULSIONS | VERTOSA INC. | 2025-01-30 | — | — | US | claimed |
| CN-118871116-A | Compounds for the treatment of cancer | 卡希夫生物科学有限公司 | 2024-10-29 | — | — | CN | claimed |
| US-20240342066-A1 | HIGH POTENCY EMULSIONS | VERTOSA INC. | 2024-10-17 | — | — | US | claimed |
| CN-117177965-A | Five-membered and six-membered compound, preparation method, pharmaceutical composition and application | 杭州多域生物技术有限公司 | 2023-12-05 | — | — | CN | claimed |
| EP-3805243-B1 | ANDROSTANE DERIVATIVES WITH ACTIVITY AS PURE OR PREDOMINANTLY PURE STIMULATORS OF SERCA2A FOR THE TREATMENT OF HEART FAILURE | WINDTREE THERAPEUTICS INC (US) | 2023-11-15 | — | — | EP | claimed |
| US-12557062-B2 | Method and apparatus for processing data flow of positioning base station, device and computer-readable medium | GREE ELECTRIC APPLIANCES (WUHAN) CO., LTD (CN) | 2026-02-17 | — | — | US | disclosed |
| EP-4652275-A1 | DELIVERY OF OLIGONUCLEOTIDES | ProQR Therapeutics II B.V. (NL) | 2025-11-26 | — | — | EP | disclosed |
| US-20250340934-A1 | SELECTIVE BLOCKING TO DETECT AND AMPLIFY LOW ABUNDANT TEMPLATE | GT MOLECULAR, INC. (US) | 2025-11-06 | — | — | US | disclosed |
| WO-2025226735-A1 | CHEMICAL IMPAIRMENT DETECTION AND PROPULSION CONTROL (CIDPC) SYSTEM | #1 A LIFESAFER, INC. (US) | 2025-10-30 | — | — | WO | disclosed |
| EP-4641119-A2 | SYSTEMS, METHODS, AND APPLIANCES THAT ENABLE REGIONAL CONTROL OF REFRIGERATION APPLIANCES | True Manufacturing Co., Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| EP-4591460-A1 | APPARATUS AND METHODS FOR PHASE DETERMINATION IN MULTI-BEAM COMMUNICATION SYSTEMS | QUALCOMM INCORPORATED (US) | 2025-07-30 | — | — | EP | disclosed |
| WO-2025122524-A1 | CONTROL SYSTEM AND METHOD | ADJ PRODUCTS, LLC (US) | 2025-06-12 | — | — | WO | disclosed |
| CN-114630826-A | Fluorinated quinoline, quinoxaline and benzo [ b ] [1,4] oxazine derivatives as dihydroorotate dehydrogenase (DHODH) inhibitors for the treatment of cancer, autoimmune and inflammatory diseases | 詹森生物科技公司 | 2022-06-14 | — | — | CN | disclosed |
| EP-4002865-A1 | SERVICE CONFIGURATION METHOD AND APPARATUS | ZTE Corporation (CN) | 2022-05-25 | — | — | EP | disclosed |
| CN-114423759-A | Condensed heteroaryl derivative, preparation method and application thereof in medicine | 江苏恒瑞医药股份有限公司 | 2022-04-29 | — | — | CN | disclosed |
| CN-108885660-B | Techniques for metadata processing | 查尔斯斯塔克德雷珀实验室有限公司 | 2022-04-05 | — | — | CN | disclosed |
| CN-114222739-A | Sulfonylurea derivatives and use thereof | 诺瑟拉有限公司 | 2022-03-22 | — | — | CN | disclosed |
| EP-3957034-A1 | SUBSCRIBER STATION FOR A SERIAL BUS SYSTEM, AND METHOD FOR COMMUNICATING IN A SERIAL BUS SYSTEM | Robert Bosch GmbH (DE) | 2022-02-23 | — | — | EP | disclosed |
| CN-113057609-B | Vital sign monitoring method and system | 吉林大学 | 2022-02-18 | — | — | CN | disclosed |
| CN-114026060-A | Acrylate derivative, use thereof, and intermediate for production thereof | 住友化学株式会社 | 2022-02-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12557062-B2 | Method and apparatus for processing data flow of positioning base station, device and computer-readable medium | RAD1, SET, BUB1 | ALDH1A1 4846/4885MAPT 2444/4885PLIN1 2868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.